Who founded Paragon Bioservices?

Paragon Bioservices was founded by Marco Chacon in 2015.

Who are Paragon Bioservices's investors?

Paragon Bioservices's investors include Camden Partners, Havencrest Capital Management.

How much funding has Paragon Bioservices raised?

Paragon Bioservices has disclosed $22.9M raised across 4 rounds.

Where is Paragon Bioservices headquartered?

Paragon Bioservices is headquartered in Baltimore, US.

Paragon Bioservices

Baltimore, US · Founded 2015 · Delaware corporation · 2 known investors

Industry-leading private-equity backed CDMO focused on development and manufacturing of cutting-edge biopharmaceuticals

Biotech

Founders & leadership

Paragon Bioservices was founded in 2015 by Marco Chacon.

Marco ChaconFounderOperating Partner at Havencrest Capital Management

Peter BuzyExecutive

Board

Patrick HervyBoard director

Christopher KerseyBoard directorFounding Managing Partner at Havencrest Capital Management

Kapila RatnamBoard director

Investors · 2

Camden PartnersOwings Mills

Havencrest Capital ManagementDallas

Reported raises · per SEC filings

Form D private placements

$22.9M disclosed across 4 rounds · 2014–2018

▶$5MraisedAug 2018 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Robert RocheDirector
Kapila RatnamDirector
Patrick HervyDirector
Peter BuzyExecutive Officer, Director
Donald HughesDirector
Marco ChaconDirector

Offering amount: $5M
Amount sold: $5M
Minimum investment: $10.4K
First sale: Aug 2018
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.4MraisedMay 2017 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Marco ChaconDirector
Robert RocheDirector
Patrick HervyDirector
Donald HughesDirector
Kapila RatnamDirector
Peter BuzyExecutive Officer, Director

Offering amount: $2.4M
Amount sold: $2.4M
Minimum investment: $20K
First sale: May 2017
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedAug 2015 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Marco ChaconExecutive Officer, Director
Patrick HervyDirector
Christopher KerseyDirector
Kapila RatnamDirector
Peter BuzyExecutive Officer

Offering amount: $4M
Amount sold: $2M
First sale: Aug 2015
Incorporated: Limited Liability Company, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$13.5MraisedNov 2014 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Marco ChaconExecutive Officer, Director
Patrick HervyDirector
Kapila RatnamDirector
Peter BuzyExecutive Officer
Christopher KerseyDirector

Offering amount: $13.5M
Amount sold: $13.5M
Sales commissions: $624.4K
Placement agents: 1st Bridgehouse Securities, LLC
First sale: Oct 2014
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Paragon Bioservices do?: Industry-leading private-equity backed CDMO focused on development and manufacturing of cutting-edge biopharmaceuticals
Who founded Paragon Bioservices?: Paragon Bioservices was founded by Marco Chacon in 2015.
Who are Paragon Bioservices's investors?: Paragon Bioservices's investors include Camden Partners, Havencrest Capital Management.
How much funding has Paragon Bioservices raised?: Paragon Bioservices has disclosed $22.9M raised across 4 rounds.
Where is Paragon Bioservices headquartered?: Paragon Bioservices is headquartered in Baltimore, US.